Cargando…
Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis
BACKGROUND: Tumor necrosis factor receptor-associated factor 6 (TRAF6) can regulate the activation of inflammatory signaling pathways by acting as an E3 ubiquitin ligase, which enhances B cell activation. This study aimed to evaluate the expression of TRAF6 in the peripheral blood B cells of myasthe...
Autores principales: | Li, Ting, Li, Yue, Li, Jia-Wen, Qin, Ying-Hui, Zhai, Hui, Feng, Bin, Li, He, Zhang, Ning-Nannan, Yang, Chun-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382794/ https://www.ncbi.nlm.nih.gov/pubmed/35978310 http://dx.doi.org/10.1186/s12883-022-02833-9 |
Ejemplares similares
-
Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum
por: Yan, Mei, et al.
Publicado: (2021) -
Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients
por: Li, Zhibin, et al.
Publicado: (2020) -
Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
por: Rao, Jie, et al.
Publicado: (2022) -
Corrigendum: Comparison of peripheral blood regulatory T cells and functional subsets between ocular and generalized myasthenia gravis
por: Rao, Jie, et al.
Publicado: (2023) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)